Skip to main content
Jun Choi, MD, Hematology, New York, NY

JunHanChoiMD

Hematology • New York, NY

Hematologic Oncology

Physician

Join to view full profile

Dr. Choi is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Choi's full profile

Already have an account?

  • Office

    240 East 38th Street
    19th Floor
    New York, NY 10016

Education & Training

  • NYU Grossman School of Medicine
    NYU Grossman School of MedicineFellowship, Hematology and Medical Oncology, 2017 - 2020
  • University of Illinois College of Medicine at Chicago
    University of Illinois College of Medicine at ChicagoResidency, Internal Medicine, 2014 - 2017
  • Boston University School of Medicine
    Boston University School of MedicineClass of 2014

Certifications & Licensure

  • NY State Medical License
    NY State Medical License 2017 - 2026
  • IL State Medical License
    IL State Medical License 2014 - 2017
  • PA State Medical License
    PA State Medical License 1973 - 1976
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Hematology
  • American Board of Internal Medicine Medical Oncology

Publications & Presentations

PubMed

Journal Articles

  • Doxercalciferol, a pro-hormone of vitamin D, prevents the development of cardiac hypertrophy in rats  
    Choi, Jun H; Ke, Qingen; Bae, Soochan; Lee, Ji Yoo; Kim, Yu Jin; Kim, Ui Kyoung; Arbeeny, Cynthia; Thadhani, Ravi; Kang, Peter M, Journal of cardiac failure
  • Acute Myeloid Leukemia Treatment in the Elderly: A Comprehensive Review of the Present and Future  
    Jun Choi, Mihir Shukla, Maher Abdul-Hay, Acta Haematol, 7/17/2023
  • Impaired Humoral Immunity to SARS-CoV-2 Vaccination in Non-Hodgkin Lymphoma and CLL Patients  
    Catherine Diefenbach, Jessica Caro, Akiko Koide, Michael Grossbard, Judith D Goldberg, Bruce Raphael, Kenneth Hymes, Tibor Moskovits, Maxim Kreditor, David Kaminetzky,..., medRxiv, 3/6/2021
  • Join now to see all

Abstracts/Posters

  • Pegasperagase Toxicity in Adult Patients with Acute Lymphoblastic Leukemia: A Single Center Experience Comparing Patients Older and Younger Than 35 Years of Age
    Choi, J H; Azzi, J; Hochman, T; Nierodzik, M L R; Saint, Fleur-Lominy S; Abdul, Hay M, Blood
  • Effect of Angiotensin Converting Enzyme Inhibitors and Angiotensin Receptor Blockers on Kidney Function in Patients with Sickle Cell Disease
    Choi, Jun; Singh, Naina; Han, Jin; Gowhari, Michel; Hassan, Johara; Jain, Shivi; Molokie, Robert E.; Gordeuk, Victor R.; Saraf, Santosh L., Blood

Press Mentions

  • Menin Inhibitor Yields 63% ORR in Heavily Pretreated Acute Leukemia
    Menin Inhibitor Yields 63% ORR in Heavily Pretreated Acute LeukemiaDecember 14th, 2023

Dr. Jun Choi, Dr. Jun Choi, MD, Dr. J Choi, Dr. Jun Han Choi